Arkstone

Arkstone is a US-based technology company specializing in advanced laboratory result analysis and antimicrobial stewardship programs.

We provide a comprehensive platform leveraging PCR and DNA sequencing interpretations to deliver actionable insights for healthcare providers. Our technology analyzes source of specimen, diagnosis, organisms, resistance genes, allergies, age, and gender, offering the most detailed and advanced antimicrobial stewardship program available.

Arkstone’s solutions are designed to combat the growing threat of antimicrobial resistance, empowering clinicians and laboratories with the data they need to make informed decisions and optimize patient care. We serve hospitals, reference laboratories, and diagnostic centers seeking to improve antibiotic utilization and patient outcomes.

Founded in 2018, Arkstone has rapidly grown to a team of 36 professionals, headquartered in Durham, North Carolina, with a secondary location in Cedarhurst, NY.